BetterLife Pharma (BETRF) Investment Income (2021 - 2024)
BetterLife Pharma (BETRF) posted quarterly Investment Income of $126505.1 for Q4 2024, up 59.23% year-over-year from $79446.5 in Q4 2023, and up 352.0% quarter-over-quarter from -$50200.9 in Q3 2024.
BetterLife Pharma (BETRF) Investment Income (2021 - 2024) Analysis & Trends
BetterLife Pharma's Investment Income history runs 4 years deep, the most recent figure standing at $126505.1 for Q4 2024.
- In Q4 2024, Investment Income rose 59.23% year-over-year to $126505.1; the TTM figure through Oct 2024 stood at $95690.7 (up 205.1% YoY), while the FY2023 annual figure was $4103.2, down 96.08% from the prior year.
- Investment Income for Q4 2024 stood at $126505.1, up from -$50200.9 in the prior quarter.
- The five-year high for Investment Income was $126505.1 in Q4 2024, with the low at -$160896.9 in Q2 2023.
- The 4-year median for Investment Income is $681.46 (2022), against an average of -$192.79.
- Peak annual rise in Investment Income reached 17399.39% in 2023, while the deepest fall reached 57828.54% in 2023.
- BetterLife Pharma's Investment Income stood at $2432.4 in 2021, then slumped by 81.34% to $454.0 in 2022, then soared by 17399.39% to $79446.5 in 2023, then soared by 59.23% to $126505.1 in 2024.
- Business Quant data shows BETRF's Investment Income at $126505.1 in Q4 2024, -$50200.9 in Q3 2024, and -$60060.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 126,505.07 |
| Jul 31, 2024 | -50,200.91 |
| Apr 30, 2024 | -60,059.96 |
| Oct 31, 2023 | 79,446.53 |
| Jul 31, 2023 | -11,992.51 |
| Apr 30, 2023 | -160,896.92 |
| Jan 31, 2023 | 2,399.89 |
| Oct 31, 2022 | 454.00 |
| Jul 31, 2022 | 908.93 |
| Apr 30, 2022 | 278.71 |
| Oct 31, 2021 | 2,432.45 |
| Jul 31, 2021 | 68,411.20 |